-
1
-
-
33644817819
-
Adrenal tumors: Introduction
-
DeLellis R, Lloyd R, Heitz P, Eng C eds, Lyon: International Agency for Research on Cancer, pp
-
Lloyd R, Tischer A, Kimura N, McNicol A and Young W Jr: Adrenal tumors: introduction. In: DeLellis R, Lloyd R, Heitz P, Eng C (eds.). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon: International Agency for Research on Cancer, pp. 136-138, 2004.
-
(2004)
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs
, pp. 136-138
-
-
Lloyd, R.1
Tischer, A.2
Kimura, N.3
McNicol, A.4
Young Jr, W.5
-
2
-
-
0029114047
-
Incidentally discovered adrenal masses
-
Kloos R, Gross M, Francis I, Korobkin M and Shapiro B: Incidentally discovered adrenal masses. Endocr Rev 16: 460-484, 1995.
-
(1995)
Endocr Rev
, vol.16
, pp. 460-484
-
-
Kloos, R.1
Gross, M.2
Francis, I.3
Korobkin, M.4
Shapiro, B.5
-
3
-
-
2442505938
-
Laparoscopic adrenalectomy of malignant adrenal neoplasms
-
Sturgeon C and Kebebew E: Laparoscopic adrenalectomy of malignant adrenal neoplasms. Surg Clin North Am 84: 755-774, 2004.
-
(2004)
Surg Clin North Am
, vol.84
, pp. 755-774
-
-
Sturgeon, C.1
Kebebew, E.2
-
4
-
-
0018719716
-
Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data
-
Hough A, Hollifield J and Page D: Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 72: 390-399, 1979.
-
(1979)
Am J Clin Pathol
, vol.72
, pp. 390-399
-
-
Hough, A.1
Hollifield, J.2
Page, D.3
-
5
-
-
0021966841
-
Morphologic characteristics of benign and malignant adrenocortical tumors
-
vanSlooten H, Schaberg A, Smeenk D and Moolenaar A: Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55: 766-773, 1985.
-
(1985)
Cancer
, vol.55
, pp. 766-773
-
-
vanSlooten, H.1
Schaberg, A.2
Smeenk, D.3
Moolenaar, A.4
-
6
-
-
0024513504
-
Pathologic features of prognostic significance in adrenocortical carcinoma
-
Weiss L, Medeiros L and Vickery A: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202-206, 1989.
-
(1989)
Am J Surg Pathol
, vol.13
, pp. 202-206
-
-
Weiss, L.1
Medeiros, L.2
Vickery, A.3
-
7
-
-
0036892571
-
Weiss system revisited: A clinicopathologic and immunohistochemical study of 49 adrenocortical tumors
-
Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau J, Lecomte-Houcke M and Leteurtre E: Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26: 1612-1619, 2002.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 1612-1619
-
-
Aubert, S.1
Wacrenier, A.2
Leroy, X.3
Devos, P.4
Carnaille, B.5
Proye, C.6
Wemeau, J.7
Lecomte-Houcke, M.8
Leteurtre, E.9
-
8
-
-
0025202883
-
Hormonal evaluation of the patient with an incidentally discovered adrenal mass
-
Ross N and Aron D: Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 323: 1401-1405, 1990.
-
(1990)
N Engl J Med
, vol.323
, pp. 1401-1405
-
-
Ross, N.1
Aron, D.2
-
9
-
-
0033665840
-
Limitations of size as a criterion in the evaluation of adrenal tumors
-
Barnett C, Jr, Varma D, El-Naggar A, Dackiw A, Porter G, Pearson A, Kudelka A, Gagel R, Evans D and Lee J: Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 128: 973-982, 2000.
-
(2000)
Surgery
, vol.128
, pp. 973-982
-
-
Barnett Jr, C.1
Varma, D.2
El-Naggar, A.3
Dackiw, A.4
Porter, G.5
Pearson, A.6
Kudelka, A.7
Gagel, R.8
Evans, D.9
Lee, J.10
-
10
-
-
0141989561
-
CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses
-
Lumachi F, Borsato S, Tregnaghi A, Basso S, Marchesi P, Ciarleglio F, Fassina A and Favia G: CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29: 689-692, 2003.
-
(2003)
Eur J Surg Oncol
, vol.29
, pp. 689-692
-
-
Lumachi, F.1
Borsato, S.2
Tregnaghi, A.3
Basso, S.4
Marchesi, P.5
Ciarleglio, F.6
Fassina, A.7
Favia, G.8
-
11
-
-
0031985748
-
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors
-
Busam K, Iversen K, Coplan K, Old L, Stocken E, Chen Y, McGregor D and Jungbluth A: Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 22: 57-63, 1998.
-
(1998)
Am J Surg Pathol
, vol.22
, pp. 57-63
-
-
Busam, K.1
Iversen, K.2
Coplan, K.3
Old, L.4
Stocken, E.5
Chen, Y.6
McGregor, D.7
Jungbluth, A.8
-
12
-
-
0033054345
-
The expression of inhibin/activin subunits in the human adrenal cortex and its tumours
-
Munro L, Kennedy A and McNicol A: The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. J Endocrinol 161: 341-347, 1999.
-
(1999)
J Endocrinol
, vol.161
, pp. 341-347
-
-
Munro, L.1
Kennedy, A.2
McNicol, A.3
-
13
-
-
0029127128
-
Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy
-
Sasano H, Shizawa S, Suzuki T, Takayama K, Fukaya T, Morohashi K and Nagura H: Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy. Hum Pathol 26: 1154-1156, 1995.
-
(1995)
Hum Pathol
, vol.26
, pp. 1154-1156
-
-
Sasano, H.1
Shizawa, S.2
Suzuki, T.3
Takayama, K.4
Fukaya, T.5
Morohashi, K.6
Nagura, H.7
-
14
-
-
0026569155
-
Cytokeratin expression in adrenocortical neoplasia: An immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma
-
Gaffey M, Traweek S, Mills S, Travis W, Lack E, Medeiros L and Weiss L: Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 23: 144-153, 1992.
-
(1992)
Hum Pathol
, vol.23
, pp. 144-153
-
-
Gaffey, M.1
Traweek, S.2
Mills, S.3
Travis, W.4
Lack, E.5
Medeiros, L.6
Weiss, L.7
-
15
-
-
40449091072
-
Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy in patients with adrenal mcidentalomas. Q
-
Giovanella L, Ceriani L, Balerna M, Keller F, Taborelli M, Marone C and Ferone D: Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy in patients with adrenal mcidentalomas. Q J Nucl Med Mol Imaging 52: 84-88, 2008.
-
(2008)
J Nucl Med Mol Imaging
, vol.52
, pp. 84-88
-
-
Giovanella, L.1
Ceriani, L.2
Balerna, M.3
Keller, F.4
Taborelli, M.5
Marone, C.6
Ferone, D.7
-
16
-
-
0024992575
-
Cellular DNA profiles of benign and malignant adrenocortical tumors
-
Cibas E, Medeiros L, Weinberg D, Gelb A and Weiss L: Cellular DNA profiles of benign and malignant adrenocortical tumors. Am J Surg Pathol 14: 948-955, 1990.
-
(1990)
Am J Surg Pathol
, vol.14
, pp. 948-955
-
-
Cibas, E.1
Medeiros, L.2
Weinberg, D.3
Gelb, A.4
Weiss, L.5
-
17
-
-
11144301227
-
Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas
-
Dziegiel P, Salwa-Zurawska W, Zurawski J, Wojnar A and Zabel M: Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol Histopathol 20: 83-89, 2005.
-
(2005)
Histol Histopathol
, vol.20
, pp. 83-89
-
-
Dziegiel, P.1
Salwa-Zurawska, W.2
Zurawski, J.3
Wojnar, A.4
Zabel, M.5
-
18
-
-
0027513696
-
Metallothionein protects DNA from oxidative damage
-
Chubatsu L and Meneghini R: Metallothionein protects DNA from oxidative damage. Biochem J 291: 193-198, 1993.
-
(1993)
Biochem J
, vol.291
, pp. 193-198
-
-
Chubatsu, L.1
Meneghini, R.2
-
19
-
-
0023781524
-
Biochemistry of metallothionein
-
Kägi J and Schäffer A: Biochemistry of metallothionein. Biochemistry 27: 8509-8515, 1988.
-
(1988)
Biochemistry
, vol.27
, pp. 8509-8515
-
-
Kägi, J.1
Schäffer, A.2
-
20
-
-
43949161668
-
Role of metallothionein in carcinogenesis
-
Cherian M, Howell S, Imura N, Klaassen C, Koropatnick J, Lazo J and Waalkes M: Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol 126: 1-5, 1994.
-
(1994)
Toxicol Appl Pharmacol
, vol.126
, pp. 1-5
-
-
Cherian, M.1
Howell, S.2
Imura, N.3
Klaassen, C.4
Koropatnick, J.5
Lazo, J.6
Waalkes, M.7
-
21
-
-
0035916994
-
Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis
-
Hengstler J, Pilch H, Schmidt M, Dahlenburg H, Sagemüller J, Schiffer I, Oesch F, Knapstein P, Kaina B and Tanner B; Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis. Int J Cancer 95: 121-127, 2001.
-
(2001)
Int J Cancer
, vol.95
, pp. 121-127
-
-
Hengstler, J.1
Pilch, H.2
Schmidt, M.3
Dahlenburg, H.4
Sagemüller, J.5
Schiffer, I.6
Oesch, F.7
Knapstein, P.8
Kaina, B.9
Tanner, B.10
-
22
-
-
0032885943
-
Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus
-
Hishikawa Y, Koji T, Dhar D, Kinugasa S, Yamaguchi M and Nagasue N: Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus. Br J Cancer 81: 712-720, 1999.
-
(1999)
Br J Cancer
, vol.81
, pp. 712-720
-
-
Hishikawa, Y.1
Koji, T.2
Dhar, D.3
Kinugasa, S.4
Yamaguchi, M.5
Nagasue, N.6
-
23
-
-
0033408518
-
Prognostic evaluation of metallothionein expression in human colorectal neoplasms
-
Ioachim E, Goussia A, Agnantis N, Machera M, Tsianos E and Kappas A: Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J Clin Pathol 52: 876-879, 1999
-
(1999)
J Clin Pathol
, vol.52
, pp. 876-879
-
-
Ioachim, E.1
Goussia, A.2
Agnantis, N.3
Machera, M.4
Tsianos, E.5
Kappas, A.6
-
24
-
-
3142742298
-
Clinicopathological significance of metallothioneins in breast cancer
-
Jin R, Huang J, Tan P and Bay B: Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10: 74-79, 2004.
-
(2004)
Pathol Oncol Res
, vol.10
, pp. 74-79
-
-
Jin, R.1
Huang, J.2
Tan, P.3
Bay, B.4
-
25
-
-
0342884840
-
High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma
-
McCluggage W, Maxwell P, Hamilton P and Jasani B: High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology 34: 51-55, 1999.
-
(1999)
Histopathology
, vol.34
, pp. 51-55
-
-
McCluggage, W.1
Maxwell, P.2
Hamilton, P.3
Jasani, B.4
-
26
-
-
0030843282
-
Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer
-
Monden N, Abe S, Sutoh I, Hishikawa Y, Kinugasa S and Nagasue N: Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology 54: 391-399, 1997.
-
(1997)
Oncology
, vol.54
, pp. 391-399
-
-
Monden, N.1
Abe, S.2
Sutoh, I.3
Hishikawa, Y.4
Kinugasa, S.5
Nagasue, N.6
-
27
-
-
0030000198
-
Immunohistochemical study of metallothionein in pancreatic carcinomas
-
Ohshio G, Imamura T, Okada N, Wang Z, Yamaki K, Kyogoku T, Suwa H, Yamabe H and Imamura M: Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 122: 351-355, 1996.
-
(1996)
J Cancer Res Clin Oncol
, vol.122
, pp. 351-355
-
-
Ohshio, G.1
Imamura, T.2
Okada, N.3
Wang, Z.4
Yamaki, K.5
Kyogoku, T.6
Suwa, H.7
Yamabe, H.8
Imamura, M.9
-
28
-
-
0031924088
-
The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma
-
Siu L, Banerjee D, Khurana R, Pan X, Pflueger R, Tannock I and Moore M: The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma. Clin Cancer Res 4: 559-565, 1998.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 559-565
-
-
Siu, L.1
Banerjee, D.2
Khurana, R.3
Pan, X.4
Pflueger, R.5
Tannock, I.6
Moore, M.7
-
29
-
-
0035046995
-
Metallothionein expression in renal cell carcinoma: Subcellular localization and prognostic significance
-
Tüzel E, Kirkali Z, Yörükoglu K, Mungan M and Sade M: Metallothionein expression in renal cell carcinoma: subcellular localization and prognostic significance. J Urol 165: 1710-1713, 2001.
-
(2001)
J Urol
, vol.165
, pp. 1710-1713
-
-
Tüzel, E.1
Kirkali, Z.2
Yörükoglu, K.3
Mungan, M.4
Sade, M.5
-
30
-
-
0032402184
-
Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival
-
Hiura T, Khalid H, Yamashita H, Tokunaga Y, Yasunaga A and Shibata S: Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Cancer 83: 2361-2369, 1998.
-
(1998)
Cancer
, vol.83
, pp. 2361-2369
-
-
Hiura, T.1
Khalid, H.2
Yamashita, H.3
Tokunaga, Y.4
Yasunaga, A.5
Shibata, S.6
-
31
-
-
0027955770
-
The human gene for nuclear protein BM28 (CDCLI), a new member of the early S-phase family of proteins, maps to chromosome band 3q21
-
Mincheva A, Todorov I, Werner D, Fink T and Lichter P: The human gene for nuclear protein BM28 (CDCLI), a new member of the early S-phase family of proteins, maps to chromosome band 3q21. Cytogenet Cell Genet 65: 276-277, 1994.
-
(1994)
Cytogenet Cell Genet
, vol.65
, pp. 276-277
-
-
Mincheva, A.1
Todorov, I.2
Werner, D.3
Fink, T.4
Lichter, P.5
-
33
-
-
0034595448
-
Uninterrupted MCM2-7 function required for DNA replication fork progression
-
Labib K, Tercero J and Diffley J: Uninterrupted MCM2-7 function required for DNA replication fork progression. Science 288: 1643-1647, 2000.
-
(2000)
Science
, vol.288
, pp. 1643-1647
-
-
Labib, K.1
Tercero, J.2
Diffley, J.3
-
34
-
-
23244467451
-
The MCM complex: Its role in DNA replication and implications for cancer therapy
-
Lei M: The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets 5: 365-380, 2005.
-
(2005)
Curr Cancer Drug Targets
, vol.5
, pp. 365-380
-
-
Lei, M.1
-
35
-
-
33746862012
-
Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy
-
Mehrotra P, Gonzalez M, Johnson S, Coleman N, Wilson J, Davies B and Lennard T: Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngoscope 116: 1434-1438, 2006.
-
(2006)
Laryngoscope
, vol.116
, pp. 1434-1438
-
-
Mehrotra, P.1
Gonzalez, M.2
Johnson, S.3
Coleman, N.4
Wilson, J.5
Davies, B.6
Lennard, T.7
-
36
-
-
0029983343
-
Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67
-
Duchrow M, Schlüter C, Wohlenberg C, Flad H and Gerdes J: Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67. Cell Proliferation 29: 1-12, 1996.
-
(1996)
Cell Proliferation
, vol.29
, pp. 1-12
-
-
Duchrow, M.1
Schlüter, C.2
Wohlenberg, C.3
Flad, H.4
Gerdes, J.5
-
37
-
-
29244436364
-
Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells
-
Zheng J, Ma T, Cao J, Sun X, Chen J, Li W, Wen R, Sun Y and Pei D: Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells. Life Sci 78: 724-729, 2006.
-
(2006)
Life Sci
, vol.78
, pp. 724-729
-
-
Zheng, J.1
Ma, T.2
Cao, J.3
Sun, X.4
Chen, J.5
Li, W.6
Wen, R.7
Sun, Y.8
Pei, D.9
-
38
-
-
0344862102
-
Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA
-
Muskhelishvili L, Latendresse J, Kodell R and Henderson E: Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem 51: 1681-1688, 2003.
-
(2003)
J Histochem Cytochem
, vol.51
, pp. 1681-1688
-
-
Muskhelishvili, L.1
Latendresse, J.2
Kodell, R.3
Henderson, E.4
-
39
-
-
33745021835
-
Ki-67 expression in operable breast cancer: A comparative study of immunostaining and a real-time RT-PCR assay
-
Potemski P, Pluciennik E, Bednarek A, Kusinska R, Kubiak R, Jesionek-Kupnicka D, Watala C and Kordek R: Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay. Pathol Res Pract 202: 491-495, 2006.
-
(2006)
Pathol Res Pract
, vol.202
, pp. 491-495
-
-
Potemski, P.1
Pluciennik, E.2
Bednarek, A.3
Kusinska, R.4
Kubiak, R.5
Jesionek-Kupnicka, D.6
Watala, C.7
Kordek, R.8
-
40
-
-
27144531772
-
Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens
-
Rubio J, Ramos D, López-Guerrero J, Iborra I, Collado A, Solsona E, Almenar S and Llombart-Bosch A: Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens. Eur Urol 48: 745-751, 2005.
-
(2005)
Eur Urol
, vol.48
, pp. 745-751
-
-
Rubio, J.1
Ramos, D.2
López-Guerrero, J.3
Iborra, I.4
Collado, A.5
Solsona, E.6
Almenar, S.7
Llombart-Bosch, A.8
-
41
-
-
10644240711
-
Oral alveolar soft-part sarcoma: Review of literature and case report with immunohistochemistry study for prognostic markers
-
do Nascimento Souza K, Faria P, Costa I, Duriguetto A, Jr and Loyola A: Oral alveolar soft-part sarcoma: review of literature and case report with immunohistochemistry study for prognostic markers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 64-70, 2005.
-
(2005)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
, vol.99
, pp. 64-70
-
-
do Nascimento1
Souza, K.2
Faria, P.3
Costa, I.4
Duriguetto Jr, A.5
Loyola, A.6
-
42
-
-
33646812936
-
Mixed small cell carcinomas of the uterine cervix: Prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index
-
Horn L, Hentschel B, Bilek K, Richter C, Einenkel J and Leo C: Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol 10: 140-143, 2006.
-
(2006)
Ann Diagn Pathol
, vol.10
, pp. 140-143
-
-
Horn, L.1
Hentschel, B.2
Bilek, K.3
Richter, C.4
Einenkel, J.5
Leo, C.6
-
43
-
-
0023340925
-
Vorschlag zur einheitlichen Definition eines immunhistochemischen Östrogenrezeptornachweises (ER-ICA) im Mamma-karzinomgewebe.
-
Remmele W and Stegner H: Vorschlag zur einheitlichen Definition eines immunhistochemischen Östrogenrezeptornachweises (ER-ICA) im Mamma-karzinomgewebe. Pathologe 8: 138-140, 1987.
-
(1987)
Pathologe
, vol.8
, pp. 138-140
-
-
Remmele, W.1
Stegner, H.2
-
44
-
-
0033028078
-
Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection
-
Harrison L, Gaudin P and Brennan M: Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134: 181-185, 1999.
-
(1999)
Arch Surg
, vol.134
, pp. 181-185
-
-
Harrison, L.1
Gaudin, P.2
Brennan, M.3
-
45
-
-
2342458182
-
Expression of metallothioneins in tumor cells
-
Dziegiel P: Expression of metallothioneins in tumor cells. Pol J Pathol 55: 3-12, 2004.
-
(2004)
Pol J Pathol
, vol.55
, pp. 3-12
-
-
Dziegiel, P.1
-
46
-
-
0036200075
-
Metallothionein 2A expression is associated with cell proliferation in breast cancer
-
Jin R, Chow V, Tan P, Dheen S, Duan W and Bay B: Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23: 81-86, 2002.
-
(2002)
Carcinogenesis
, vol.23
, pp. 81-86
-
-
Jin, R.1
Chow, V.2
Tan, P.3
Dheen, S.4
Duan, W.5
Bay, B.6
-
47
-
-
33847660185
-
Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer
-
Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E and Zabel M: Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res 27: 335-342, 2007.
-
(2007)
Anticancer Res
, vol.27
, pp. 335-342
-
-
Pastuszewski, W.1
Dziegiel, P.2
Krecicki, T.3
Podhorska-Okolow, M.4
Ciesielska, U.5
Gorzynska, E.6
Zabel, M.7
-
48
-
-
0035728745
-
Discerning malignancy in resected adrenocortical neoplasms
-
Sasano H, Suzuki T and Moriya T: Discerning malignancy in resected adrenocortical neoplasms. Endocr Pathol 12: 397-406, 2001.
-
(2001)
Endocr Pathol
, vol.12
, pp. 397-406
-
-
Sasano, H.1
Suzuki, T.2
Moriya, T.3
-
49
-
-
34347354300
-
Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma
-
Sasano H, Suzuki T and Moriya T: Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 17: 345-354, 2006.
-
(2006)
Endocr Pathol
, vol.17
, pp. 345-354
-
-
Sasano, H.1
Suzuki, T.2
Moriya, T.3
-
50
-
-
0041387353
-
Adrenocortical adenoma and carcinoma: Histopathological and molecular comparative analysis
-
Stojadinovic A, Brennan M, Hoos A, Omeroglu A, Leung D, Dudas M, Nissan A, Cordon-Cardo C and Ghossein R: Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis. Mod pathol 16: 742-751, 2003.
-
(2003)
Mod pathol
, vol.16
, pp. 742-751
-
-
Stojadinovic, A.1
Brennan, M.2
Hoos, A.3
Omeroglu, A.4
Leung, D.5
Dudas, M.6
Nissan, A.7
Cordon-Cardo, C.8
Ghossein, R.9
-
51
-
-
33744476143
-
Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid
-
Cho Mar K, Eimoto T, Nagaya S and Tateyama H: Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 48: 801-807, 2006.
-
(2006)
Histopathology
, vol.48
, pp. 801-807
-
-
Cho Mar, K.1
Eimoto, T.2
Nagaya, S.3
Tateyama, H.4
-
52
-
-
0036179331
-
Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barren's mucosa
-
Going J, Keith W, Neilson L, Stoeber K, Stuart R and Williams G: Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barren's mucosa. Gut 50: 373-377, 2002.
-
(2002)
Gut
, vol.50
, pp. 373-377
-
-
Going, J.1
Keith, W.2
Neilson, L.3
Stoeber, K.4
Stuart, R.5
Williams, G.6
-
53
-
-
23944515316
-
Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: A multivariate survival study including proliferation markers and cell cycle regulators
-
Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E and Patsouris E: Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol 36: 899-907, 2005.
-
(2005)
Hum Pathol
, vol.36
, pp. 899-907
-
-
Korkolopoulou, P.1
Givalos, N.2
Saetta, A.3
Goudopoulou, A.4
Gakiopoulou, H.5
Thymara, I.6
Thomas-Tsagli, E.7
Patsouris, E.8
-
54
-
-
33745535972
-
Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma
-
Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, Jelen M, Matkowski R, Pomiecko A, Spytkowska B, Jagas M, Gisterek I and Kornafel J: Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res 26: 2473-2478, 2006.
-
(2006)
Anticancer Res
, vol.26
, pp. 2473-2478
-
-
Szelachowska, J.1
Dziegiel, P.2
Jelen-Krzeszewska, J.3
Jelen, M.4
Matkowski, R.5
Pomiecko, A.6
Spytkowska, B.7
Jagas, M.8
Gisterek, I.9
Kornafel, J.10
-
55
-
-
42149136945
-
Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours
-
Vargas P, Cheng Y, Barrett A, Craig G and Speight P: Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J Oral Pathol Med 2008.
-
(2008)
J Oral Pathol Med
-
-
Vargas, P.1
Cheng, Y.2
Barrett, A.3
Craig, G.4
Speight, P.5
-
56
-
-
55749100743
-
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
-
Yang J, Ramnath N, Moysich K, Asch H, Swede H, Alrawi S, Huberman J, Geradts J, Brooks J and Tan D: Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer 1: 203, 2003.
-
(2003)
BMC Cancer
, vol.1
, pp. 203
-
-
Yang, J.1
Ramnath, N.2
Moysich, K.3
Asch, H.4
Swede, H.5
Alrawi, S.6
Huberman, J.7
Geradts, J.8
Brooks, J.9
Tan, D.10
-
57
-
-
0141792846
-
Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: Correlation with expression of Ki-67 and estrogen and progesterone receptors
-
Kato K, Toki T, Shimizu M, Shiozawa T, Fujii S, Nikaido T and Konishi I: Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors. Int J Gynecol Pathol 22: 334-340, 2003.
-
(2003)
Int J Gynecol Pathol
, vol.22
, pp. 334-340
-
-
Kato, K.1
Toki, T.2
Shimizu, M.3
Shiozawa, T.4
Fujii, S.5
Nikaido, T.6
Konishi, I.7
-
58
-
-
33847168993
-
Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer
-
Ananthanarayanan V, Deaton R, Yang X, Pins M and Gann P: Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer 17: 73, 2006.
-
(2006)
BMC Cancer
, vol.17
, pp. 73
-
-
Ananthanarayanan, V.1
Deaton, R.2
Yang, X.3
Pins, M.4
Gann, P.5
|